Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Breast cancer in systemic lupus erythematosus

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Intrahepatic Oxaliplatin and Systemic 5-FU +/- Cetuximab in Chemo-Naïve Patients with Liver Metastases from Colorectal Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Dual Inhibition of EGFR and VEGF in Heavily Pretreated Patients with Metastatic Colorectal Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Results from a Phase I Study of Lapatinib with Gemcitabine and Cisplatin in Advanced or Metastatic Bladder Cancer: EORTC Trial 30061

    Research output: Contribution to journalJournal articleResearchpeer-review

  • B Tessier Cloutier
  • A E Clarke
  • R Ramsey-Goldman
  • Yu Wang
  • W Foulkes
  • Colin Beattie Gordon
  • J E Hansen
  • E Yelin
  • M B Urowitz
  • D Gladman
  • P R Fortin
  • D J Wallace
  • M Petri
  • S Manzi
  • E M Ginzler
  • J Labrecque
  • S Edworthy
  • M A Dooley
  • J L Senécal
  • C A Peschken
  • S C Bae
  • D Isenberg
  • Awahan Rahman
  • G Ruiz-Irastorza
  • J G Hanly
  • Søren Jacobsen
  • O Nived
  • T Witte
  • L A Criswell
  • S G Barr
  • L Dreyer
  • G Sturfelt
  • S Bernatsky
View graph of relations
Evidence points to a decreased breast cancer risk in systemic lupus erythematosus (SLE). We analyzed data from a large multisite SLE cohort, linked to cancer registries.
Original languageEnglish
JournalOncology
Volume85
Issue number2
Pages (from-to)117-21
Number of pages5
ISSN0030-2414
DOIs
Publication statusPublished - 2013

    Research areas

  • Adult, Aged, Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular, Cohort Studies, Disease Susceptibility, Female, Humans, Logistic Models, Lupus Erythematosus, Systemic, Middle Aged, Multivariate Analysis, Odds Ratio, Risk Factors

ID: 42182800